Health Care
Oman’s Health Ministry Launches Oxford-AstraZeneca Vaccination Campaign
Muscat: The Sultanate’s Ministry of Health today launched a campaign targeting a new segment of the society as part of its COVID-19 national immunization drive using the Oxford-AstraZeneca vaccine.
The campaign targets people aged 65 and above across all governorates of the Sultanate, irrespective of whether they are ‘healthy’ or not. The vaccine will be given at designated immunization centres.
Also Read: The Sultanate Receives 100,000 Doses Of Oxford AstraZeneca Vaccine
The two-dose vaccine will be administered in intervals of four weeks.
It should be noted that people who have already received the first dose of Pfizer-bioNTech will not be given the new vaccine. The Oman News Agency confirmed that the Ministry of Health will announce the date of applying for the second dose of Pfizer-BioNTech later.
The Minister also stated that the preliminary indication is that the vaccines are effective against the new strains of the virus.
Speaking to the media in a press conference, the minister said: “The Serum Institute of India (SII) is one of the largest vaccine factories in the world.
The Minister also confirmed that the step to obtain the vaccine reinforces the global efforts aimed at overcoming the Coronavirus pandemic and make vaccines available among all people of the world.
-
Banking & Finance2 months agoBank Muscat posts net profit of RO137.49 million in H1 2026
-
Highlights4 weeks agoOERLive: Top 10 Mathematical Problems AI Has Solved or Transformed
-
Magazines3 weeks agoOER Magazine July Edition 2026
-
Banking & Finance2 months agoOman Housing Bank launches digital waiting list for housing loans
-
Magazines3 weeks agoAl Mar’a Magazine July 2026
-
Alamaliktistaad Magazines3 weeks agoAlam Al-Iktisaad Magazine July 2026 Edition
-
Banking & Finance1 month agoOman Arab Bank CEO Sulaiman Al Harthi Retires as Ali Al Mani Is Named Successor
-
Banking & Finance1 month agoOERLive ANALYSIS: The Coldcard Hack Shows Why Bitcoin Self-Custody Remains Difficult for Ordinary Users
